Company intelligence / Profile preview

AEI24

Zaragoza, Zaragoza, Spainaei24.com ↗
Ownership
Private
Development stage
Other
01

Overview

AEI24 (Aragonesa De Exportacion Internacional 24 SL) is a Spanish pharmaceutical company founded in 2012 that specializes in the development, licensing, and export of over-the-counter (OTC) products, nutraceuticals, cosmetics, and medical devices. The company operates internationally with offices in Spain, Portugal, Ireland, and Brazil, exporting its portfolio to over 90 countries across five continents. AEI24's product line includes Easycol BABY+ (a lactase enzyme supplement for infant colic), Fortiferrum (liposomal iron supplements), Strippsol (fast-dissolving oral films utilizing their proprietary MultiLAY technology), and the DentYucral oral care line tailored for specific populations like diabetics and smokers. The company actively collaborates with academic institutions such as the University of Zaragoza, University of Minho, and Sapienza University of Rome to develop its healthcare solutions.

Therapeutic areas
PsychiatryWomen's HealthGastroenterologyDermatologyInfectious DiseasesEndocrinologyHematologyMetabolic Disorders
Modalities
Small moleculeRecombinant proteinBiologicDeviceBotanical extractPeptides
Industry
Pharma
02

Drug pipeline

3 assets

Easycol Baby

Unknown

2 more assets in the full pipeline.

Beyond the preview

Go deeper on AEI24.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AEI24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call